Surging Demand for Whey Protein Driven by Health Trends and Weight-Loss Drugs

Global dairy producers are investing heavily in expanding their whey production capabilities to meet the rising demand for protein-rich whey, driven primarily by the increased use of weight-loss drugs and a trend towards healthier eating. According to data from StoneX consultancy, the price of whey protein concentrate with 80% protein content (WPC 80) has skyrocketed by nearly 90% over the past year, reaching 20,000 euros ($23,410) per metric ton.

This price surge has outpaced other dairy segments, including powdered milk and cheese. The demand is largely attributed to the growing popularity of GLP-1 weight-loss drugs, which have led consumers to seek out protein to prevent muscle loss. Luis Cubel, managing director of Arla Foods Ingredients, noted the industry's need to identify untapped volumes of whey to satisfy this demand.

In response, companies like Arla Foods and FrieslandCampina have increased their whey production capacity. FrieslandCampina recently completed the acquisition of Wisconsin Whey Protein and has doubled its capacity at its Borculo plant in the Netherlands. The company has also announced an investment exceeding 90 million euros to accelerate its growth in high-value whey proteins.

The Dairy Farmers of America (DFA) has also adapted to this trend by launching MULU, a cottage cheese enriched with whey protein, containing 18 grams of complete protein per half-cup serving. This is a significant increase compared to the typical 12 to 13 grams found in standard products.

Additionally, the popularity of high-protein diets has spurred interest in alternative protein sources such as peas and lentils, offering new revenue streams for US farmers. Biotech firms are exploring precision fermentation to create alternative proteins, although high costs remain a barrier to widespread adoption.